Clinical Trials

NCT03516942 | ACTIVE_NOT_RECRUITING
565 participants

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-07
Start Date:
2018-06-11
Completion:
2023-12-31
Conditions
  • Stage I Colon Cancer AJCC v8
  • Stage I Rectal Cancer AJCC v8
  • Stage II Colon Cancer AJCC v8
  • Stage II Rectal Cancer AJCC v8
  • Stage IIA Colon Cancer AJCC v8
  • Stage IIA Rectal Cancer AJCC v8
  • Stage IIB Colon Cancer AJCC v8
  • Stage IIB Rectal Cancer AJCC v8
  • Stage IIC Colon Cancer AJCC v8
  • Stage IIC Rectal Cancer AJCC v8
  • Stage III Colon Cancer AJCC v8
  • Stage III Rectal Cancer AJCC v8
  • Stage IIIA Colon Cancer AJCC v8
  • Stage IIIA Rectal Cancer AJCC v8
  • Stage IIIB Colon Cancer AJCC v8
  • Stage IIIB Rectal Cancer AJCC v8
  • Stage IIIC Colon Cancer AJCC v8
  • Stage IIIC Rectal Cancer AJCC v8
Interventions
  • OTHER
NCT03504644 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
40 participants

Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2018-08-13
Completion:
2025-07-22
Conditions
  • Recurrent Adult Lymphoblastic Lymphoma
  • Recurrent B Acute Lymphoblastic Leukemia
  • Recurrent B Lymphoblastic Lymphoma
  • Recurrent T Acute Lymphoblastic Leukemia
  • Recurrent T Lymphoblastic Lymphoma
  • Refractory B Acute Lymphoblastic Leukemia
  • Refractory B Lymphoblastic Lymphoma
  • Refractory T Acute Lymphoblastic Leukemia
  • Refractory T Lymphoblastic Lymphoma
Interventions
  • PROCEDURE
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page